PRMT5 inhibitors
US10947234B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2018 |
| Grant date | Mar 16, 2021 |
| Priority date | — |
| Expiry date | Nov 5, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a compound of Formula (I) or the pharmaceutically acceptable salts thereof, which are PRMT5 inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.